HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-05-08Clinical Trial Update: Reaching 90 90 90 in Adolescents in Zambia: Using All Our SKILLZ [NA]
A completed clinical trial in Zambia assessing adolescent HIV-related and sexual health outcomes has posted results as part of efforts to re…
-
CLINICAL_TRIALS research · 2024-05-08Clinical Trial Update: Patient-Reported Outcomes in Real-life of Cabotegravir and Rilpivirine
This is a clinical trial update evaluating patient-reported quality of life in real-life use of cabotegravir and rilpivirine for HIV treatme…
-
CLINICAL_TRIALS trial_result · 2024-05-07Clinical Trial Update: Impact of Raltegravir Intensification on HIV-1-infected Subjects With Complete Viral Suppression Under Monotherapy With Protease Inhibitors [Phase 3]
Phase 3 trial evaluating the impact of adding raltegravir to protease inhibitor monotherapy in HIV-1 infected individuals with sustained vir…
-
CLINICAL_TRIALS trial_result · 2024-05-07Clinical Trial Update: SSRI Effects on Depression and Immunity in HIV/AIDS [Phase 4]
Phase 4 trial evaluating SSRIs' effects on depression and immune markers in people with HIV/AIDS. Results were posted in May 2024.
-
CLINICAL_TRIALS trial_result · 2024-05-07Clinical Trial Update: A Phase I, Randomized, Double-Blind, Placebo-Controlled Safety, Tolerability and Immunogenicity Study of Candidate HIV-1 Vaccines ChAdOx1.HTI and MVA.HTI With Recombinant HIV-1 Envelope Protein ConM SOSIP.v7 gp140 Vaccine, Adjuvanted With MPLA Liposomes in ART-Suppressed HIV-1 Positive Individuals [Phase 1]
Phase 1 randomized, double-blind, placebo-controlled study evaluating safety, tolerability, and immunogenicity of HIV-1 vaccines ChAdOx1.HTI…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-05-07Clinical Trial Update: Safety and Immunogenicity of ChAdV63.HIVconsv and MVA.HIVconsv Candidate HIV-1 Vaccines in Recently HIV-1 Infected Individuals [Phase 1]
Phase 1 trial assessing safety and immunogenicity of two HIV vaccine candidates, ChAdV63.HIVconsv and MVA.HIVconsv, in individuals recently …
-
CLINICAL_TRIALS trial_result · 2024-05-07Clinical Trial Update: Study to Evaluate the Safety and Effect of HIVconsv Vaccines in Combination With Histone Deacetylase Inhibitor Romidepsin on the Viral Rebound Kinetic After Treatment Interruption in Early Treated HIV-1 Infected Individuals [Phase 1]
A Phase 1 trial studied the safety and potential impact of combining the HIVconsv vaccine with romidepsin on viral rebound after treatment i…
-
CLINICAL_TRIALS research · 2024-05-07Clinical Trial Update: Expression of Stress Markers During Meth Treatment (EXPRESS+) [NA]
A UCLA-led clinical trial update investigating expression of stress markers during methamphetamine treatment in people with substance use di…
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: Tailoring Shared Decision Making for Lung Cancer Screening in Persons Living With HIV
A completed clinical trial evaluated tailoring shared decision making for lung cancer screening among people living with HIV, with results p…
-
CLINICAL_TRIALS withdrawal · 2024-05-03Clinical Trial Update: Safety and Efficacy of Neutralizing Antibodies and Vaccination for Induction of HIV Remission [Phase 1]
A Phase 1 clinical trial evaluating neutralizing antibodies and vaccination to induce HIV remission has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2024-05-02Clinical Trial Update: A Study of Switching to RPV Plus Other ARVs in HIV-1-infected Children (Aged 2 to <12 Years) Who Are Virologically Suppressed [Phase 2]
Phase 2 study evaluating switching to rilpivirine-containing regimens in virologically suppressed HIV-1-infected children aged 2 to <12 year…
-
CLINICAL_TRIALS trial_result · 2024-05-02Clinical Trial Update: Reducing Post-Hospital Mortality in HIV-infected Adults in Tanzania [NA]
A clinical trial in Tanzania evaluating approaches to reduce post-hospital mortality among HIV-infected adults has completed and posted resu…
-
CLINICAL_TRIALS trial_result · 2024-05-01Clinical Trial Update: Maraviroc Efficacy for Hepatitis C [Phase 4]
Phase 4 clinical trial update assessing maraviroc for hepatitis C in HIV-infected individuals; the study has completed and results were post…
-
CLINICAL_TRIALS research · 2024-05-01Clinical Trial Update: A Phase 1 Study to Evaluate the Safety and Immunogenicity of eOD-GT8 60mer mRNA Vaccine (mRNA-1644) and Core-g28v2 60mer mRNA Vaccine (mRNA-1644v2-Core) [Phase 1]
This clinical trial update describes a Phase 1 study evaluating the safety and immunogenicity of two experimental HIV vaccines, eOD-GT8 60me…
-
CLINICAL_TRIALS trial_result · 2024-04-30Clinical Trial Update: Self-management of HIV Among Adolescents [NA]
This update reports the completion of a clinical trial evaluating self-management strategies for HIV among adolescents.
-
CLINICAL_TRIALS research · 2024-04-29Clinical Trial Update: Long-Acting Treatment in Adolescents (LATA) [Phase 3]
A Phase 3 clinical trial called LATA is evaluating a long-acting HIV treatment for adolescents and is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2024-04-26Clinical Trial Update: Rapid Reinitiation of a Single Tablet Antiretroviral Therapy Using Symtuza® in HIV-1 Infected Treatment-Experienced Patients Off Therapy. (ReSTART) [Phase 4]
This Phase 4 trial (ReSTART) tested rapid reinitiation of Symtuza in HIV-1-infected, treatment-experienced patients off therapy. The study h…
-
CLINICAL_TRIALS trial_result · 2024-04-25Clinical Trial Update: A Study of CL-197 Capsules in Healthy Participants [Phase 1]
Phase 1 trial evaluating the safety and pharmacokinetics of CL-197 capsules in healthy participants, with HIV-1 listed as the condition.
-
CLINICAL_TRIALS research · 2024-04-25Clinical Trial Update: Integrating a Stepped Care Model of Screening and Treatment for Depression Into Malawi's National HIV Care Delivery Platform [Phase 4]
Phase 4 clinical trial update on integrating a stepped care model for depression screening and treatment into Malawi's national HIV care pla…
-
CLINICAL_TRIALS trial_result · 2024-04-25Clinical Trial Update: Clinical Effectiveness-Implementation Hybrid Type 2 Study on Home-Delivered Cabenuva for People Living With HIV Who Are Not Retained in Care
An ongoing hybrid effectiveness-implementation study is evaluating home-delivered Cabenuva for people living with HIV who are not retained i…
-
FDA approval · 2024-04-24FDA Approved: BIKTARVY — Supplemental Application (Gilead Sciences, Inc.)
FDA approved a supplemental application for BIKTARVY (bictegravir, emtricitabine, and tenofovir alafenamide) from Gilead Sciences, for its H…
-
CLINICAL_TRIALS trial_result · 2024-04-19Clinical Trial Update: Immunologic Response to Kansui in Treated HIV+ Individuals: a Dose Escalation Study [Phase 1]
Phase 1 dose-escalation study evaluating immunologic response to Kansui in treated HIV+ individuals; the study is terminated with results po…
-
FDA approval · 2024-04-18FDA Approved: TIVICAY — Supplemental Application (ViiV Healthcare Company)
The FDA approved a supplemental application for Tivicay (dolutegravir) submitted by ViiV Healthcare Company.
-
FDA approval · 2024-04-18FDA Approved: DOVATO — Supplemental Application (ViiV Healthcare Company)
The FDA approved a supplemental application for DOVATO (dolutegravir and lamivudine) from ViiV Healthcare Company to update the drug’s label…
-
FDA approval · 2024-04-18FDA Approved: TIVICAY PD — Supplemental Application (ViiV Healthcare Company)
The FDA has approved a supplemental application for Tivicay PD (dolutegravir) from ViiV Healthcare Company.